SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Scrip Dividend Reference Share Price

16 Apr 2026 14:59

RNS Number : 8131A
CLS Holdings PLC
16 April 2026
 
 

CLS Holdings plc

("CLS" or the "Company")

Scrip Dividend Reference Share Price - 2025 Final Dividend

On 13 March 2026 the Company announced its final results for the year ending 31 December 2025 and that it would be recommending a 2025 final dividend of 2.7 pence per ordinary share of 2.5 pence each (a "Share"), fully paid as a Property Income Distribution (the "2025 Final Dividend").

Conditional upon the requisite resolutions being approved by shareholders at the 2026 Annual General Meeting, an enhanced scrip dividend is being offered to shareholders in respect of the 2025 Final Divided, as an alternative to the receiving the 2025 Final Dividend in cash (the "Enhanced Scrip Dividend Alternative").

If the resolutions required to offer the Enhanced Scrip Dividend Alternative are approved by the requisite majority at the 2026 Annual General Meeting, Shareholders who elect to participate in the Enhanced Scrip Dividend Alternative would receive new Shares with a value calculated on the basis of a discount of 5% to the Scrip Reference Share Price of 48.2 pence per Share.

This Scrip Reference Share Price is calculated as the average of the middle market quotations of a Share, derived from the London Stock Exchange Daily Official List, for the five Business Days starting on the day the Shares are first quoted ex-dividend, being from 9 April 2025 to 15 April 2025 (inclusive).

The deadline for applications for the Enhanced Scrip Dividend Alternative in respect of the 2025 Final Dividend is 5 pm (London time) on 30 April 2026. More details of the Enhanced Scrip Dividend Alternative, including details on how to elect to receive the Enhanced Scrip Dividend Alternative, are available on the Company's website at www.clsholdings.com.

 

-ends-

For further information, please contact:

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

David Fuller, Company Secretary

+44 (0)20 7582 7766

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVAKABPNBKDOQD
Date   Source Headline
11th Jun 20264:28 pmRNSDirector/PDMR Shareholding
2nd Jun 202610:23 amRNSDirector/PDMR Shareholding
29th May 202612:00 pmRNSTotal Voting Rights
28th May 20264:20 pmRNSDirector/PDMR Shareholding
26th May 20264:38 pmRNSTR-1: Notification of major holdings
22nd May 20265:04 pmRNSAdmission of Further Securities to Trading
15th May 20261:05 pmRNSApplication for Listing - Enhanced Scrip Dividend
13th May 202612:07 pmRNSDirector/PDMR Shareholding
30th Apr 20261:05 pmRNSDirector/PDMR Shareholding
29th Apr 20262:12 pmRNSDirector/PDMR Shareholding
27th Apr 20267:00 amRNSCLS announces sale of The Brix, Essen
23rd Apr 20264:00 pmRNSResult of AGM
16th Apr 20262:59 pmRNSScrip Dividend Reference Share Price
15th Apr 202612:32 pmRNSDirector/PDMR Shareholding
9th Apr 20263:07 pmRNSTR-1: Notification of major holdings
25th Mar 20269:58 amRNSTR-1: Notification of major holdings
23rd Mar 20264:05 pmRNSPublication of 2025 Annual Report & Notice of AGM
16th Mar 20265:46 pmRNSDirector/PDMR Shareholding
13th Mar 20263:45 pmRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSAnnual Financial Results
13th Mar 20267:00 amRNSAnnual Financial Results
10th Feb 20264:03 pmRNSDirector/PDMR Shareholding
13th Jan 20264:37 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20253:30 pmRNSChanges to the responsibilities of a director
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
22nd Dec 20257:00 amRNSCitadel Place: Conditional sale & Planning update
9th Dec 20253:12 pmRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSTrading Update
12th Nov 20254:12 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSBoard Change/CFO Appointment
16th Oct 20257:00 amRNSCLS leases 14,700 sqm at Gotic Haus, Dortmund
10th Oct 202511:00 amRNSDirector/PDMR Shareholding
15th Sep 20259:00 amRNSTR-1 Notification of Major Holdings
9th Sep 20253:48 pmRNSDirector/PDMR Shareholding
14th Aug 20255:13 pmRNSDirector/PDMR Shareholding
13th Aug 20257:01 amRNSHalf Yearly Results Announcement 2025
13th Aug 20257:00 amRNSBoard Appointment
11th Aug 20256:11 pmRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSCLS secures over 8,000 sq. ft at The Coade
6th Aug 20257:00 amRNSCLS leases 2,165 sqm in Cologne
9th Jul 20259:49 amRNSDirector/PDMR Shareholding
3rd Jul 20251:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20251:34 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCLS sells two properties in Germany
30th Jun 202511:48 amRNSBoard Change
11th Jun 20253:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:57 pmRNSDirector/PDMR Shareholding
16th May 20254:35 pmRNSResult of AGM
13th May 20254:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.